• Previous studies have described efforts to evaluate claims-based algorithms for identifying patients with hypertension (HTN). 1,2 • Algorithms which include multiple medical claims with a diagnosis of HTN or those that combine the presence of a medical claim for HTN with a pharmacy claim for an antihypertensive appear to have the best balance of sensitivity and specificity. 1,2 • Robinson et al. found more self-reported HTN cases confirmed by administrative data when the number of years of claims increased 3 . In identifying diabetic patients, Herbert et al. observed a 10% increase in sensitivity with a small drop in specificity when two rather than one year of claims data were used. 4 • Although there is wide use of claims-based algorithms in identifying HTN patients for research studies and health plan based care initiatives, few researchers have included the number of years of claims data in their algorithm evaluation.
• Further investigation of the performance of a wide range of claims-based algorithms using administrative data with different observation time periods is warranted.
OBJECTIVE
To examine the performance of various administrative claims-based algorithms with varying observation times for identifying HTN patients.
• Patients who received care from a single medical group in the Northeast United States between 11/01/2010 to 12/21/2013 and had eligibility within health plan(s) in the HealthCore Integrated Research Database (HIRD TM ) were linked.
• Patients had at least one year continuous enrollment in a commercial health plan within the HIRD prior to their first EMR record.
• Relevant medical record data was extracted from the medical group's electronic medical record (EMR) system and linked to the medical and pharmacy claims data contained within the HIRD.
• A diagnosis of HTN from the EMR patient problem list was considered the gold standard for detecting the presence of HTN.
• Seven claims-based algorithms were tested to identify HTN patients utilizing two observation time periods, 11/2010 to 12/2013 (EMR data availability) and 01/2006 to 12/2013 (entire claims data availability). (Table 1) -For medical claims, a diagnosis of HTN was identified using ICD-9 codes 401.xx, 402.xx, 403.xx, or 404.xx.
-From pharmacy claims, we identified antihypertensive medications using generic product identifier (GPI) codes starting with 33, 34, 36 and 37.
• Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) was computed for each of the claims-based algorithms and the two observation time periods.
• Kappa was calculated to evaluate the degree of overall agreement.
• Statistical analysis was conducted using SAS® Version 9.4 (SAS Institute Inc., Cary, NC).
• From a total of 10,864 patients with integrated data, 3,272 were identified with hypertension in the EMR.
• The identified HTN patients had an average age of 72.5±11.6 years old and 63% were female. 21.4% had diagnosis of diabetes and 7.0% had chronic kidney disease. 76.8% had at least one pharmacy claim for antihypertensive medication within 12 months. (Table 2) • Kappa statistic values for each of the algorithms and time observation periods were similar and all reflected substantial agreement 5 between the claims-based algorithms and the EMR diagnoses for HTN.
• This study analyzed data from the EMR of one medical group practice in a single geographic region, and assumed that the HTN diagnosis in the patient problem list of the EMR is the gold standard. Coding of diagnoses in the EMR and billing systems in this practice may not be representative of the broader medical practice population.
• Further research involving multiple practice sites and regions would help to improve the study validity and generalizability.
• Sensitivity and negative predictive value (NPV) was higher for algorithms when a fewer number of medical claims required a HTN diagnosis and for algorithms run in claims data with a longer observation period. (Figures 1 and 4) • Specificity and positive predictive value (PPV) was higher for algorithms requiring more medical claims with a HTN diagnosis and for algorithms run in claims data with a shorter observation period. (Figures 2 and 3) • The length of the observation period had a greater impact on PPV than on NPV. The differences in PPV by observation time period in the various claims-based algorithms ranged from 10.0 to 14.4%, while the differences in NPV were only 3.2 to 6.2%. (Figure 3 and 4) • While there was some effect observed on the algorithm performance characteristics by varying the number of claims observed and the type of claims utilized (medical only [algorithms 1-3] vs. medical and pharmacy [algorithms 4-7] ), the magnitude of this difference appeared to be minimal. (Figures 1-4 
REFERENCES CONCLUSIONS
• Performance characteristics of claims-based algorithms for identifying HTN patients vary on specific criteria utilized and length of observation time of the data.
• In this analysis, length of observation time appeared to have more of an influence on the performance characteristics of the claims-based algorithms than did the types/number of claims utilized in the algorithm.
• Researchers and those utilizing research based on identification of cohorts or outcome events utilizing claims-based algorithms should consider how the length of observation time in addition to the specific algorithm utilized may affect interpretation of the results of these studies.
• Selection of the most appropriate claims-based algorithm and length of observation time for any particular study or case/event finding purpose ultimately depends on whether it is more important to identify all possible cases/events or be more certain of the validity of those cases/events identified.
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